These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36893936)

  • 1. Temporal changes in the utilization of kidneys from hepatitis C virus-infected donors in the United States.
    Buchanan-Peart KA; Pagan J; Martin E; Turkeltaub J; Reese P; Goldberg DS
    Am J Transplant; 2023 Jun; 23(6):831-838. PubMed ID: 36893936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation.
    Leeaphorn N; Attieh RM; Wadei HM; Mao SA; Mao MA; Pungpapong S; Taner B; Cheungpasitporn W; Jarmi T
    Transplant Proc; 2024; 56(6):1513-1521. PubMed ID: 38997885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.
    Chang SH; Merzkani M; Lentine KL; Wang M; Axelrod DA; Anwar S; Schnitzler MA; Wellen J; Chapman WC; Alhamad T
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):251-261. PubMed ID: 33451990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.
    Potluri VS; Goldberg DS; Mohan S; Bloom RD; Sawinski D; Abt PL; Blumberg EA; Parikh CR; Sharpe J; Reddy KR; Molnar MZ; Sise M; Reese PP
    J Am Soc Nephrol; 2019 Oct; 30(10):1939-1951. PubMed ID: 31515244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of hepatitis C virus-positive donors in kidney transplantation.
    Shetty A; Ariyamuthu VK; Gungor AB; Tanriover B
    Curr Opin Organ Transplant; 2023 Feb; 28(1):22-28. PubMed ID: 36227758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
    Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus Infection.
    Sise ME; Goldberg DS; Kort JJ; Schaubel DE; Alloway RR; Durand CM; Fontana RJ; Brown RS; Friedewald JJ; Prenner S; Landis JR; Fernando M; Phillips CC; Woodle ES; Rike-Shields A; Sherman KE; Elias N; Williams WW; Gustafson JL; Desai NM; Barnaba B; Norman SP; Doshi M; Sultan ST; Aull MJ; Levitsky J; Belshe DS; Chung RT; Reese PP
    J Am Soc Nephrol; 2020 Nov; 31(11):2678-2687. PubMed ID: 32843477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
    Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
    Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy.
    Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM
    Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.
    Friebus-Kardash J; Gäckler A; Kribben A; Witzke O; Wedemeyer H; Treckmann J; Herzer K; Eisenberger U
    Transpl Infect Dis; 2019 Oct; 21(5):e13146. PubMed ID: 31306562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Opioid Crisis on the Donor Pool for Kidney Transplantation: An Analysis of National Kidney Deceased Donor Trends from 2010-2016.
    Chute DF; Sise ME
    Am J Nephrol; 2018; 47(2):84-93. PubMed ID: 29439266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.
    Molnar MZ; Nair S; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Podila PSB; Mas V; Maluf D; Helmick RA; Campos L; Nezakatgoo N; Eymard C; Horton P; Verma R; Jenkins AH; Handley CR; Snyder HS; Cummings C; Agbim UA; Maliakkal B; Satapathy SK; Eason JD
    Am J Transplant; 2019 Nov; 19(11):3046-3057. PubMed ID: 31306549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.
    Daloul R; Pesavento TE; Goldberg DS; Reese PP
    Kidney Int; 2021 Dec; 100(6):1190-1198. PubMed ID: 34237327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
    Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
    Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.